9.20
Teladoc Health Inc stock is traded at $9.20, with a volume of 4.28M.
It is up +1.10% in the last 24 hours and up +22.02% over the past month.
Teladoc Health Inc is engaged in the provision of virtual healthcare services, connecting patients, providers, and healthcare systems through technology-enabled platforms. The company has two reportable segments: Integrated Care and BetterHelp. The Integrated Care segment provides virtual healthcare solutions, including primary care, mental health, chronic care management, and telehealth enablement services for employers, insurers, and healthcare systems, mainly on a business-to-business basis, while the BetterHelp segment offers direct-to-consumer online mental health services, including counseling and therapy delivered through digital platforms. It generates the majority of its revenue from the Integrated Care segment.
See More
Previous Close:
$9.10
Open:
$9.11
24h Volume:
4.28M
Relative Volume:
0.90
Market Cap:
$1.66B
Revenue:
$2.51B
Net Income/Loss:
$-171.15M
P/E Ratio:
-9.5505
EPS:
-0.9633
Net Cash Flow:
$122.59M
1W Performance:
+16.31%
1M Performance:
+22.02%
6M Performance:
+30.50%
1Y Performance:
+10.18%
Teladoc Health Inc Stock (TDOC) Company Profile
Name
Teladoc Health Inc
Sector
Industry
Phone
(203) 635-2002
Address
155 E 44TH STREET, NEW YORK, NY
Compare TDOC vs VEEV, BTSG, TEM, HQY, HNGE
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
TDOC
Teladoc Health Inc
|
9.20 | 1.53B | 2.51B | -171.15M | 122.59M | -0.9633 |
|
VEEV
Veeva Systems Inc
|
192.74 | 28.83B | 3.32B | 941.65M | 1.64B | 5.6161 |
|
BTSG
Brightspring Health Services Inc
|
69.03 | 13.69B | 13.65B | 169.86M | 412.12M | 1.0758 |
|
TEM
Tempus Ai Inc
|
60.27 | 10.40B | 1.36B | -302.91M | -219.93M | -1.7182 |
|
HQY
Healthequity Inc
|
95.31 | 7.55B | 1.34B | 230.70M | 440.96M | 2.6695 |
|
HNGE
Hinge Health Inc
|
84.05 | 6.42B | 646.34M | -512.40M | 202.76M | -6.6871 |
Teladoc Health Inc Stock (TDOC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-10-26 | Upgrade | Deutsche Bank | Hold → Buy |
| Feb-26-26 | Upgrade | BofA Securities | Neutral → Buy |
| Dec-09-25 | Initiated | Barclays | Equal Weight |
| Nov-13-25 | Initiated | BMO Capital Markets | Market Perform |
| Jul-25-25 | Initiated | Mizuho | Neutral |
| Nov-15-24 | Initiated | Goldman | Buy |
| Sep-17-24 | Reiterated | Jefferies | Hold |
| Feb-29-24 | Initiated | Cantor Fitzgerald | Overweight |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Jan-17-24 | Downgrade | DA Davidson | Buy → Neutral |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Apr-12-23 | Initiated | Stephens | Equal-Weight |
| Feb-23-23 | Upgrade | SVB Securities | Market Perform → Outperform |
| Oct-24-22 | Upgrade | Guggenheim | Sell → Neutral |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Sep-07-22 | Initiated | Truist | Hold |
| Aug-17-22 | Downgrade | Guggenheim | Neutral → Sell |
| Aug-12-22 | Initiated | DA Davidson | Buy |
| Aug-02-22 | Downgrade | Berenberg | Buy → Hold |
| Aug-02-22 | Downgrade | Cowen | Outperform → Market Perform |
| Jul-28-22 | Downgrade | Goldman | Buy → Neutral |
| Jul-28-22 | Downgrade | Needham | Buy → Hold |
| Jul-06-22 | Reiterated | BofA Securities | Neutral |
| May-05-22 | Downgrade | Argus | Buy → Hold |
| Apr-28-22 | Downgrade | Citigroup | Buy → Neutral |
| Apr-28-22 | Downgrade | Credit Suisse | Outperform → Neutral |
| Apr-28-22 | Downgrade | Guggenheim | Buy → Neutral |
| Apr-28-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Apr-28-22 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Apr-28-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Apr-28-22 | Downgrade | William Blair | Outperform → Mkt Perform |
| Apr-07-22 | Initiated | Guggenheim | Buy |
| Apr-01-22 | Resumed | Credit Suisse | Outperform |
| Mar-03-22 | Upgrade | Argus | Hold → Buy |
| Feb-23-22 | Reiterated | BofA Securities | Neutral |
| Feb-23-22 | Reiterated | Craig Hallum | Hold |
| Feb-23-22 | Reiterated | Evercore ISI | In-line |
| Feb-23-22 | Reiterated | Goldman | Buy |
| Feb-23-22 | Reiterated | JP Morgan | Overweight |
| Feb-23-22 | Reiterated | KeyBanc Capital Markets | Overweight |
| Feb-23-22 | Reiterated | Needham | Buy |
| Feb-23-22 | Reiterated | Oppenheimer | Outperform |
| Feb-23-22 | Reiterated | Stifel | Hold |
| Feb-11-22 | Initiated | Goldman | Buy |
| Feb-08-22 | Reiterated | Piper Sandler | Overweight |
| Dec-02-21 | Resumed | Jefferies | Hold |
| Nov-22-21 | Downgrade | BTIG Research | Buy → Neutral |
| Oct-28-21 | Reiterated | Barclays | Equal Weight |
| Oct-28-21 | Reiterated | BofA Securities | Neutral |
| Oct-28-21 | Reiterated | Canaccord Genuity | Buy |
| Oct-28-21 | Reiterated | Citigroup | Buy |
| Oct-28-21 | Reiterated | Craig Hallum | Hold |
| Oct-28-21 | Reiterated | Needham | Buy |
| Oct-28-21 | Reiterated | Oppenheimer | Outperform |
| Oct-28-21 | Reiterated | Piper Sandler | Overweight |
| Oct-28-21 | Reiterated | UBS | Neutral |
| Oct-19-21 | Initiated | Wells Fargo | Overweight |
| Aug-02-21 | Downgrade | Argus | Buy → Hold |
| Jul-28-21 | Downgrade | Deutsche Bank | Buy → Hold |
| May-28-21 | Initiated | Robert W. Baird | Neutral |
| Apr-15-21 | Initiated | Needham | Buy |
| Jan-07-21 | Initiated | BTIG Research | Buy |
| Dec-22-20 | Initiated | Evercore ISI | In-line |
| Dec-07-20 | Downgrade | Stephens | Overweight → Equal-Weight |
| Dec-04-20 | Initiated | Goldman | Neutral |
| Nov-13-20 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Sep-22-20 | Initiated | DA Davidson | Buy |
| Sep-02-20 | Upgrade | Berenberg | Hold → Buy |
| Aug-17-20 | Upgrade | Credit Suisse | Neutral → Outperform |
| Jul-14-20 | Initiated | Citigroup | Buy |
| Jul-13-20 | Initiated | Argus | Buy |
| Jul-07-20 | Initiated | Stephens | Overweight |
| Apr-30-20 | Reiterated | KeyBanc Capital Markets | Overweight |
| Apr-13-20 | Initiated | SVB Leerink | Outperform |
| Mar-31-20 | Downgrade | Berenberg | Buy → Hold |
| Mar-25-20 | Downgrade | Craig Hallum | Buy → Hold |
| Mar-16-20 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Mar-12-20 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Feb-28-20 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Feb-12-20 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jan-10-20 | Initiated | UBS | Neutral |
| Jan-09-20 | Downgrade | BofA/Merrill | Buy → Neutral |
View All
Teladoc Health Inc Stock (TDOC) Latest News
Insider Sell: Kelly Bliss Sells 2,500 Shares of Teladoc Health I - GuruFocus
Teladoc Health (NYSE: TDOC) exec sells $22,500 under 10b5-1 plan - Stock Titan
Form 144 Teladoc Health For: 1 July By Investing.com - Investing.com Canada
TDOC (NYSE) insider sale notices: 10,179 shares sold in June 2026 - Stock Titan
Teladoc Health president Kelly Bliss sells $21,250 in common stock - Investing.com UK
Teladoc Health president Kelly Bliss sells $21,250 in common stock By Investing.com - Investing.com Nigeria
Form 4 Teladoc Inc For: 30 June By Investing.com - Investing.com Nigeria
Teladoc (TDOC) Stock Falls Amid Market Uptick: What Investors Need to Know - Yahoo Finance
Teladoc Health (TDOC) executive sells 2,500 shares in 10b5-1 trade - Stock Titan
Teladoc Health, Inc.(NYSE:TDOC) dropped from Russell Small Cap Comp Growth Benchmark - marketscreener.com
Teladoc Health, Inc.(NYSE: TDOC) dropped from Russell 2500 Growth Benchmark - marketscreener.com
Remitly and Teladoc Shares Skyrocket, What You Need To Know - Barchart.com
Teladoc (TDOC) Moves 6.1% Higher: Will This Strength Last? - Yahoo Finance
Form 144 Teladoc Health For: 29 June By Investing.com - Investing.com Australia
Affiliate files Form 144 to sell 2,500 restricted shares (TDOC) - Stock Titan
Teladoc Health (TDOC) Faces Broad Russell Index Exit Is Its Investment Narrative Being Rewritten? - simplywall.st
Dr. Ethan Berke: Most Influential Clinical Executives 2026 - Modern Healthcare News
Teladoc Health, Inc.(NYSE: TDOC) dropped from Russell 2000 Growth Benchmark - marketscreener.com
Teladoc Health, Inc.(NYSE: TDOC) dropped from Russell 3000E Growth Benchmark - marketscreener.com
Teladoc Health, Inc.(NYSE: TDOC) dropped from Russell 3000 Growth Benchmark - marketscreener.com
Price to book forward of Teladoc Health, Inc. – NYSE:TDOC - TradingView
Enterprise value to revenue forward of Teladoc Health, Inc. – NYSE:TDOC - TradingView
Price to sales forward of Teladoc Health, Inc. – NYSE:TDOC - TradingView
TDOC News | TELADOC HEALTH INC (NYSE:TDOC) - ChartMill
Teladoc Health, Inc. Shs Unsponsored Brazilian Depositary Receipt Repr 1 Sh - TradingView
4LL Forecast — Price Target — Prediction for 2027 - TradingView
Teladoc Health, Inc. Actuals & Estimates (NYSE:TDOC) - TradingView
Teladoc Health, Inc. Actuals & Estimates (MUN:4LL) - TradingView
Does Medicare Cover Telehealth? Yes, Here’s What to Know - GoodRx
Teladoc Health (TDOC) Short Interest & Short Float | Updated Jun 2026 - MarketBeat
Teladoc (TDOC) Ascends While Market Falls: Some Facts to Note - Yahoo Finance
Teladoc offerings are now available on Walmart’s Better Care Services - MSN
TDOCTeladoc Health Inc Latest SEC Filings - Finviz
(TDOC) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Teladoc Health Inc (TDOC) Institutional Confidence - TradingKey
Teladoc Health Inc (TDOC) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Daily Brief Health Care: Abbvie Inc, Blueprint Medicines, Cardiff Oncology, Fusion Antibodies , Guangdong True Health Medical Technology Development, High Tide , Nasos Pharma, Teladoc Health, Inc. and more - Smartkarma
Teladoc Health extends rally to seventh straight session - MSN
Primary360 from Teladoc Health Inc.virtual GP service with annual employer pricing - AD HOC NEWS
Form 13G Teladoc Health For: 22 June By Investing.com - Investing.com South Africa
Voss entities and Travis Cocke report 9.03M shares in Teladoc (TDOC) - Stock Titan
3 Non-Pharma Firms That Could Benefit From the GLP-1 Trend - MarketBeat
Healthcare Services Market Size to Worth USD 20.10 Trillion by 2035, Amid Rising Digital Healthcare Adoption – SNS Insider - GlobeNewswire Inc.
Teladoc: Stagnant Growth Suggests Telehealth Still A Solution Waiting For A Problem (TDOC) - Seeking Alpha
Teladoc Health (TDOC) Extends Winning Streak with 6% Gain - GuruFocus
Teladoc Health Inc (TDOC) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Teladoc Health Inc (TDOC) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Teladoc Health Inc (TDOC) Valuation: PE, PB & Fair Value Analysis - TradingKey
Teladoc Health Inc (TDOC) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Teladoc Health Inc (TDOC) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Telehealth Software Market Is Going to Boom |• Teladoc Health • Amwell • Doxy.me - openPR.com
Teladoc Health Inc Stock (TDOC) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):